This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gunawardane, R. N. Articles by Brugge, J. S. Search for Related Content PubMed PubMed Citation Articles by Gunawardane, R. N. Articles by Brugge, J. S.

Novel Role for PDEF in Epithelial Cell Migration and Invasion

¹ Department of Cell Biology, Harvard Medical School; ² Department of Pathology, Harvard Medical School, Molecular Pathology Research Unit, Massachusetts General Hospital; ³ Children's Hospital, Harvard Medical School, Boston, Massachusetts; and ⁴ Brown University, Providence, Rhode Island

Requests for reprints: Joan S. Brugge, Department of Cell Biology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115. Phone: 617-432-3974; Fax: 617-432-3969; E-mail: joan_brugge{at}hms.harvard.edu.

Cell migration and invasion are two critical cellular processes that are often deregulated during tumorigenesis. To identify factors that contribute to oncogenic progression by stimulating cell migration, we conducted a powerful retroviral based migration screen using an MCF7 cDNA library and the immortalized human breast epithelial cell line MCF-10A. We identified prostate derived Ets factor (PDEF), an Ets transcription factor that is overexpressed in both prostate and breast carcinoma, as a candidate promigratory gene from this screen. Whereas PDEF induced limited motility of MCF-10A cells, coexpression of PDEF with the receptor tyrosine kinases (RTK) ErbB2 and colony-stimulating factor receptor (CSF-1R)/CSF-1 significantly enhanced MCF-10A motility. Furthermore, cells coexpressing PDEF with either ErbB2 or CSF-1R/CSF-1 induced a dramatic invasive phenotype in three-dimensional cultures. Constitutive activation of the extracellular signal–regulated kinase (ERK) pathway also enhanced PDEF-induced motility and invasion, suggesting that activation of the ERK/mitogen-activated protein kinase by ErbB2 and CSF-1R/CSF-1 can cooperate with PDEF to promote motility and invasion. Furthermore, PDEF promoted anchorage-independent growth of ErbB2 and CSF-1R/CSF-1–expressing cells. Using laser capture microdissection, we also found that PDEF mRNA is overexpressed in breast tumor epithelia throughout tumor progression. Taken together, these findings suggest that the transcription factor PDEF may play an important role in breast tumorigenesis and that PDEF overexpression may be particularly significant in tumors that exhibit activation of oncogenic RTKs such as ErbB2 and CSF-1R. (Cancer Res 2005; 65(24): 11572-80)

This article has been cited by other articles:

				A. K. Sood, J. Wang, P. Mhawech-Fauceglia, B. Jana, P. Liang, and J. Geradts Sam-Pointed Domain Containing Ets Transcription Factor in Luminal Breast Cancer Pathogenesis Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1899 - 1903. [Abstract] [Full Text] [PDF]

				B. Kumar, S. Koul, L. Khandrika, R. B. Meacham, and H. K. Koul Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype Cancer Res., March 15, 2008; 68(6): 1777 - 1785. [Abstract] [Full Text] [PDF]

				X. Gu, L. F. Zerbini, H. H. Otu, M. Bhasin, Q. Yang, M. G. Joseph, F. Grall, T. Onatunde, R. G. Correa, and T. A. Libermann Reduced PDEF Expression Increases Invasion and Expression of Mesenchymal Genes in Prostate Cancer Cells Cancer Res., May 1, 2007; 67(9): 4219 - 4226. [Abstract] [Full Text] [PDF]

				T. Schmelzle, A. A. Mailleux, M. Overholtzer, J. S. Carroll, N. L. Solimini, E. S. Lightcap, O. P. Veiby, and J. S. Brugge Functional role and oncogene-regulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and morphogenesis PNAS, March 6, 2007; 104(10): 3787 - 3792. [Abstract] [Full Text] [PDF]

				D. P. Turner, O. Moussa, M. Sauane, P. B. Fisher, and D. K. Watson Prostate-Derived ETS Factor Is a Mediator of Metastatic Potential through the Inhibition of Migration and Invasion in Breast Cancer Cancer Res., February 15, 2007; 67(4): 1618 - 1625. [Abstract] [Full Text] [PDF]

				M. Lacroix Significance, detection and markers of disseminated breast cancer cells Endocr. Relat. Cancer, December 1, 2006; 13(4): 1033 - 1067. [Abstract] [Full Text] [PDF]

				Y. Chen, M. Dokmanovic, W. D. Stein, R. J. Ardecky, and I. B. Roninson Agonist and Antagonist of Retinoic Acid Receptors Cause Similar Changes in Gene Expression and Induce Senescence-like Growth Arrest in MCF-7 Breast Carcinoma Cells. Cancer Res., September 1, 2006; 66(17): 8749 - 8761. [Abstract] [Full Text] [PDF]

				M. Overholtzer, J. Zhang, G. A. Smolen, B. Muir, W. Li, D. C. Sgroi, C.-X. Deng, J. S. Brugge, and D. A. Haber Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon PNAS, August 15, 2006; 103(33): 12405 - 12410. [Abstract] [Full Text] [PDF]